0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

PREDNISONE AND PREDNISOLONE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

Edmund L. Dubois, M.D.
JAMA. 1956;161(5):427-433. doi:10.1001/jama.1956.02970050029007.
Text Size: A A A
Published online

• Prednisone and prednisolone were used in treating 31 patients with active systemic lupus erythematosus. The pattern of clinical improvement closely paralleled that obtained in previous work with corticotropin and cortisone. The fever abated in 24 to 48 hours, joint pains disappeared in several days, and pleural effusions and cutaneous lesions subsided in one to two weeks.

The necessary dosages of these two drugs, in milligrams, are smaller than those for corticotropin and cortisone; side-effects were slower in appearing; and there was less sodium retention than with hydrocortisone. Nevertheless, when high dosages are required, a low-sodium diet is necessary in order to avoid edema and congestive heart failure and a regimen to prevent peptic ulcer must also be instituted. Two patients who received the largest doses developed sudden, severe glycosuria that was cleared up in one case by changing therapy to hydrocortisone and in the other by giving insulin.

The evident effectiveness of these two drugs, and their advantages in some situations, must be weighed against their increased ulcerogenic activity and their diabetogenic potency.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();